These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11926745)

  • 41. Efficacy of ganciclovir and cidofovir against human cytomegalovirus replication in SCID mice implanted with human retinal tissue.
    Bidanset DJ; Rybak RJ; Hartline CB; Kern ER
    Antiviral Res; 2004 Jul; 63(1):61-4. PubMed ID: 15196821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with wild-type CMV in her plasma.
    Moss HB; Chavala S; Say E; Miller MB
    J Clin Microbiol; 2012 May; 50(5):1796-9. PubMed ID: 22337988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience.
    El-Haddad D; El Chaer F; Vanichanan J; Shah DP; Ariza-Heredia EJ; Mulanovich VE; Gulbis AM; Shpall EJ; Chemaly RF
    Antiviral Res; 2016 Oct; 134():58-62. PubMed ID: 27582067
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New reporter cell line to evaluate the sequential emergence of multiple human cytomegalovirus mutations during in vitro drug exposure.
    Gilbert C; Boivin G
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4860-6. PubMed ID: 16304146
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus.
    Allice T; Busca A; Locatelli F; Falda M; Pittaluga F; Ghisetti V
    J Antimicrob Chemother; 2009 Mar; 63(3):600-8. PubMed ID: 19147520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus.
    O'Brien MS; Markovich KC; Selleseth D; DeVita AV; Sethna P; Gentry BG
    Antiviral Res; 2018 Oct; 158():255-263. PubMed ID: 30153445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance.
    Chou S; Miner RC; Drew WL
    J Infect Dis; 2000 Dec; 182(6):1765-8. PubMed ID: 11069251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiviral treatment of cytomegalovirus infection and resistant strains.
    Schreiber A; Härter G; Schubert A; Bunjes D; Mertens T; Michel D
    Expert Opin Pharmacother; 2009 Feb; 10(2):191-209. PubMed ID: 19236193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-dose Valganciclovir Treatment for Resistant Cytomegalovirus Colitis due to UL97 and UL54 Mutations.
    Baradhi KM; Aure RL; El-Amm JM
    Transplant Proc; 2018; 50(1):142-144. PubMed ID: 29407298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity.
    Mousavi-Jazi M; Schloss L; Drew WL; Linde A; Miner RC; Harmenberg J; Wahren B; Brytting M
    J Clin Virol; 2001 Dec; 23(1-2):1-15. PubMed ID: 11595579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.
    Scott GM; Ng HL; Morton CJ; Parker MW; Rawlinson WD
    J Gen Virol; 2005 Aug; 86(Pt 8):2141-2151. PubMed ID: 16033961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome.
    Cherrington JM; Fuller MD; Lamy PD; Miner R; Lalezari JP; Nuessle S; Drew WL
    J Infect Dis; 1998 Dec; 178(6):1821-5. PubMed ID: 9815243
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients.
    Boivin G; Goyette N; Gilbert C; Roberts N; Macey K; Paya C; Pescovitz MD; Humar A; Dominguez E; Washburn K; Blumberg E; Alexander B; Freeman R; Heaton N; Covington E
    J Infect Dis; 2004 May; 189(9):1615-8. PubMed ID: 15116297
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sequence analysis of UL54 and UL97 genes and evaluation of antiviral susceptibility of human cytomegalovirus isolates obtained from kidney allograft recipients before and after treatment.
    Mousavi-Jazi M; Hökeberg I; Schloss L; Zweygberg-Wirgart B; Grillner L; Linde A; Brytting M
    Transpl Infect Dis; 2001 Dec; 3(4):195-202. PubMed ID: 11844151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug-resistant cytomegalovirus in transplant recipients: a French cohort study.
    Hantz S; Garnier-Geoffroy F; Mazeron MC; Garrigue I; Merville P; Mengelle C; Rostaing L; Saint Marcoux F; Essig M; Rerolle JP; Cotin S; Germi R; Pillet S; Lebranchu Y; Turlure P; Alain S;
    J Antimicrob Chemother; 2010 Dec; 65(12):2628-40. PubMed ID: 20961907
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CMV resistance: "more complicated than we thought".
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):37-9. PubMed ID: 11363529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence and characterization of cytomegalovirus resistance mutations among pediatric solid organ transplant patients who received valganciclovir prophylaxis.
    Martin M; Goyette N; Ives J; Boivin G
    J Clin Virol; 2010 Apr; 47(4):321-4. PubMed ID: 20138805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fatal cytomegalovirus pneumonia after preemptive antiviral therapy in a renal transplant recipient.
    Ketteler M; Preuschof L; Mertz A; Stöffler-Meilicke M; Schäfer H; Distler A; Offermann G
    Clin Nephrol; 2000 Nov; 54(5):418-24. PubMed ID: 11105806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resistance of human cytomegalovirus to antiviral drugs.
    Erice A
    Clin Microbiol Rev; 1999 Apr; 12(2):286-97. PubMed ID: 10194460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparison of the in vitro sensitivity to cidofovir and ganciclovir of clinical cytomegalovirus isolates. Coordinated Action Group 11].
    Houhou-Fidouh N; Mazeron MC; Dewilde A; Thouvenot D; Scieux C; Aissa N; Carquin J; Freymuth F
    Pathol Biol (Paris); 1998 Jun; 46(6):420-2. PubMed ID: 9769874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.